This facilitates flexible use by clinicians and patient acceptance
The populations studied ranged in size from 1222 (SOLOIST-WHF) to 17,160 (DECLARE) and were of similar age (range 61 to 71.9 years)
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with comorbidities
Our treatment can support those dealing with obesity and other health issues related to weight
This combination of enhanced focus, improved mood, and increased energy levels creates a positive feedback loop, with one user summarizing, "It boosted my energy and social interactions, making me more proactive and positive." Most participants dislike the current snack options in supermarkets Overall satisfaction with current snack options Most users don't like the snacks they can buy now
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
